NCT02949973View on ClinicalTrials.gov

Aurinia Early Urinary Protein Reduction Predicts Response

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

February 17, 2017

Conditions
Lupus Nephritis
Interventions
DRUG

voclosporin

Trial Locations (2)

50586

AURION Site, Kuala Lumpur

56000

AURION Site, Kuala Lumpur

Sponsors
All Listed Sponsors
lead

Aurinia Pharmaceuticals Inc.

INDUSTRY